For a more accurate diagnosis of DFSP, the National Comprehensive Cancer Network guidelines recommend hematoxylin and eosin staining along with immunostaining for markers such as CD34, factor XIIIa, tenascin, and/or stromelysin-3 [22]–[24]. This evidence concerns the gene MMP11 and dermatofibrosarcoma protuberans.